γ-carboxyglutamic acid content of hepatocellular carcinoma-associated des-γ-carboxy prothrombin

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1586, Issue 3, 2002, Pages 287-298

  Naraki, Toru ^a   Kohno, Noriatsu ^b   Saito, Hiroyuki ^c   Fujimoto, Yoshinori ^c   Ohhira, Motoyuki ^d   Morita, Takashi ^b   Kohgo, Yutaka ^c  

^a EISAI CO LTD   (Japan)

^b MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d Social Welfare Service Hakodate Hospital   (Japan)

Author keywords

Carboxylation order; Des carboxy prothrombin; Gla content; Hepatocellular carcinoma; PIVKA II

Indexed keywords

4 CARBOXYGLUTAMIC ACID; AMINO ACID; ANTIBODY; CARBONIC ACID DERIVATIVE; DECARBOXYPROTHROMBIN; EPITOPE; GLUTAMIC ACID; POLYPEPTIDE;

ADSORPTION; AMINO ACID SUBSTITUTION; ARTICLE; BENIGN TUMOR; CARBOXYLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DOMAIN;

1-CARBOXYGLUTAMIC ACID; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; BIOLOGICAL MARKERS; BLOOD COAGULATION FACTORS; CALCIUM; CARCINOMA, HEPATOCELLULAR; CATIONS, DIVALENT; CELL LINE; EDETIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FACTOR IX; FACTOR X; HUMANS; LIVER DISEASES; MOLECULAR SEQUENCE DATA; PROTEIN PRECURSORS; PROTHROMBIN; RATS; TUMOR CELLS, CULTURED;

EID: 0037165762     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(01)00107-7     Document Type: Article

References (53)

1. Prothrombin antigen and coagulation activity in patients with liver disease
2. Acquired vitamin K-dependent carboxylation deficiency in liver disease
3. Immunoassays of human prothrombin species which correlate with functional coagulation activities
4. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma
5. Clinical evaluation of plasma abnormal prothrombin (PIVKA-II) in patients with hepatocellular carcinoma
6. Serum des-gamma-carboxyprothrombin concentration determination determined by the avidin-biotin complex method in small hepatocellular carcinomas
7. Rising incidence of hepatocellular carcinoma in the United States
8. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
9. Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma
10. Isolation and characterization of a hepatoma-associated abnormal (des-gamma-carboxy) prothrombin
11. Monoclonal antibodies against human abnormal (des-gamma-carboxy) prothrombin specific for the calcium-free conformer of prothrombin
12. Production of a new monoclonal antibody specific to human des-gamma-carboxyprothrombin in the presence of calcium ions. Application to the development of a sensitive ELISA-test
13. Specific measurement of hypocarboxylated prothrombin in plasma or serum and application to the diagnosis of hepatocellular carcinoma
14. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns
15. Detection of vitamin deficiency by use of an enzyme-linked immunosorbent assay for circulating abnormal prothrombin
16. Development and evaluation of EIA kit for the detection of PIVKA-II using double antibody sandwich system: Monoclonal antibody to PIVKA-II and polyclonal antibody to prothrombin (in Japanese)
17. Clinical significance of abnormal prothrombin (DCP) in relation to postoperative survival and prognosis in patients with hepatocellular carcinoma
18. The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma
19. Sensitive measurement of serum abnormal prothrombin (PIVKA-II) as a marker of hepatocellular carcinoma
20. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases
21. Measurement of serum levels of des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma by a revised enzyme immunoassay kit with increased sensitivity
22. A simultaneous monitoring of Lens culinaris agglutinin A-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin as an early diagnosis of hepatocellular carcinoma in the follow-up of cirrhotic patients
23. Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein
24. Chemical modification of gamma-carboxyglutamic acid residues in prothrombin elicits a conformation similar to that of abnormal (des-gamma-carboxy) prothrombin
25. Distribution of gamma-carboxyglutamic acid residues in partially carboxylated human prothrombins
26. Location of gamma-carboxyglutamyl residues in partially carboxylated prothrombin preparation
27. The importance of specific gamma-carboxyglutamic acid residues in prothrombin
28. Process of carboxylation of glutamic acid residues in the Gla domain of human des-gamma-carboxyprothrombin
29. The synthesis of sulfated dextran beads for isolation of human plasma coagulation factors II, IX, and X
30. Characterization of rat factors X and Xa: Demonstration of factor Xa in rat plasma
31. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
32. Studies on the activation of bovine prothrombin
33. Slab gel system for resolution of oligopeptides below molecular weight of 10,000
34. Automatic recording apparatus for use in the chromatography of amino acids
35. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose
36. Decarboxylation of gamma-carboxyglutamic acid residues in human prothrombin
37. An improved method for the determination of gamma-carboxyglutamic acid in proteins, bone and urine
38. Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin
39. Nucleotide sequence of the gene for human factor IX (antihemophilic factor B)
40. Complete amino acid sequence of the light chain of human blood coagulation factor X: Evidence for identification of residues 63 as β-hydroxyaspartic acid
41. CDNA sequence of rat prothrombin
42. 2+ prothrombin fragment including the conformation of the Gla domain
43. Prothrombin requires two sequential metal-dependent conformational transitions to bind phospholipid
44. Nucleotide sequence of prothrombin gene in abnormal prothrombin-producing hepatocellular carcinoma cell lines
45. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: Overproduction of immunoreactive prothrombin in hepatocellular carcinoma
46. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue
47. Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinoma
48. Vitamin K contents in liver tissue of hepatocellular carcinoma patients
49. The effect of IL-6 on the des-gamma-carboxy prothrombin synthesis in human hepatoma cells
50. A missense mutation in gamma-glutamyl carboxylase gene causes combined deficiency of all vitamin K-dependent blood coagulation factors
51. The acquired vitamin K-dependent gamma-carboxylation deficiency in hepatocellular carcinoma involves not only prothrombin, but also protein C
52. Elevation of different des-gamma-carboxyproteins in hepatocellular carcinoma